IFNs transduce signals by binding to cell surface receptors and activating cellular pathways and regulatory networks that control transcription of IFN-stimulated genes (ISGs) and mRNA translation, leading to generation of protein products that mediate biological responses. Previous studies have shown that type I IFN receptorengaged pathways downstream of AKT and mammalian target of rapamycin complex (mTORC) 1 play important roles in mRNA translation of ISGs and the generation of IFN responses, but the roles of mTORC2 complexes in IFN signaling are unknown. We provide evidence that mTORC2 complexes control IFN-induced phosphorylation of AKT on serine 473 and their function is ultimately required for IFN-dependent gene transcription via interferon-stimulated response elements. We also demonstrate that such complexes exhibit regulatory effects on other IFN-dependent mammalian target of rapamycin-mediated signaling events, likely via engagement of the AKT/mTORC1 axis, including IFN-induced phosphorylation of S6 kinase and its effector rpS6, as well as phosphorylation of the translational repressor 4E-binding protein 1. We also show that induction of ISG protein expression and the generation of antiviral responses are defective in Rictor and mLST8-KO cells. Together, our data provide evidence for unique functions of mTORC2 complexes in the induction of type I IFN responses and suggest a critical role for mTORC2-mediated signals in IFN signaling.
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T he cytokine family of IFNs includes several groups and members with diverse pleiotropic biological functions, including antiviral, immunomodulatory, and growth-inhibitory properties (1, 2) . Over the years, IFNs have found various clinical applications and have been used extensively in the treatment of malignancies, viral syndromes, and neurological disorders such as multiple sclerosis (3, 4) . IFNs generate their effects on target cells by binding to specific cell surface receptors and activating associated JAK kinases. JAK kinases phosphorylate and activate STAT proteins, which translocate to the nucleus and bind to the promoters of IFN-stimulated genes (ISGs) (2, 5, 6) . Such IFN-activated JAK-STAT pathways are critical for the generation of IFN responses, as they control transcription of ISGs, ultimately giving rise to protein products that mediate the biological effects of IFNs (2, 5, 6) . Several ancillary pathways are also activated by IFNs (6) and play roles in transcription and/or mRNA translation of ISGs. Among these pathways are the p38 MAP kinase pathway (7, 8) , the MAP kinase kinase/ERK/MAPK signal-interacting kinase cascade (9, 10) , and the PI3K-AKTmammalian target of rapamycin (mTOR) signaling pathway (11) (12) (13) (14) (15) (16) . p38 MAPK-generated signals complement the function of JAK-STAT pathways and are required for optimal transcription of ISGs (8) , whereas Mnk-and AKT-mTOR signaling events are required for ISG mRNA translation (14) (15) (16) (17) (18) (19) .
In previous work, we demonstrated that the mTOR pathway is activated by the type I IFN receptor (IFNR) and have dissected the roles of various components of this signaling cascade in the generation of IFN responses. By using murine embryonic fibroblast (MEF) cells with genetic disruption of various elements of the mTOR pathway, we demonstrated that the translational suppressor 4E-binding protein 1 (4E-BP1) and tuberous sclerosis proteins, TSC1 and TSC2, exert negative regulatory roles in the generation of IFN responses (13) . In other studies, we have shown that the AKT kinase is engaged by IFNs and plays an essential regulatory role in mRNA translation of ISGs (14) . mTOR exists in two complexes, mTOR complex (mTORC) 1 and mTORC2 (20) (21) (22) , with mTORC2 regulating phosphorylation of AKT at its serine 473 site (20) (21) (22) (23) . mTORC1 comprises mTOR, mLST8, Raptor, and Pras40, whereas mTORC2 is composed of mTOR, Rictor, Sin1, and mLST8 (20) (21) (22) (23) (24) (25) (26) (27) . Although mLST8 is present in mTORC1 and mTORC2 complexes, it has been shown that the phenotype of the mLST8-KO embryos resembles that of the Rictor KO (27) . In addition, there is evidence that mLST8 is more important for the assembly of mTORC2 than mTORC1 (27) .
In the present study, we used cells with targeted disruption of various components of mTORC2, including Rictor, Sin1, and mLST8, to examine the roles of mTORC2 complexes in the generation of type I IFN responses. Our studies show that mTORC2 plays essential roles in the ultimate expression of ISG products and the generation of IFN biological responses. In contrast to what has been shown for growth factor signaling and prooncogenic responses, S6 kinase (S6K) and rpS6 appear to require upstream engagement of mTORC2, to be regulated and activated downstream of IFNactivated mTORC1. Such unexpected relative specificity raises the possibility of differential functions and activities of mTORC2 in response to cytokines with growth suppressive properties vs. cytokines and growth factors that promote cell proliferation.
Results
Rictor is an essential component of mTORC2 and is required for assembly and function of this complex (22) (23) (24) (25) (27) (28) (29) , whereas mTORC2 phosphorylates serine 473 site in the hydrophobic motif of AKT (22) (23) (24) 29) . In initial studies, we examined the ability of IFN-α to induce AKT phosphorylation in MEFs with targeted disruption of the Rictor gene (30) . As expected, there was induction of AKT phosphorylation on Ser-473 in a Type I IFN-dependent manner in WT MEFs (Fig. 1A) . However, such phosphorylation was defective in Rictor −/− MEFs (Fig. 1A) , establishing that Rictor is required for IFN-dependent Ser-473 phosphorylation. We also examined the ability of IFN to induce phosphorylation of AKT in MEFs with genetic disruption of two other genes, Sin1 (31) and mLST8 (27), the protein products of which are also required for assembly and function of the mTORC2 complex. Type I IFN-induced phosphorylation of AKT on Ser-473 was defective in MEFs with genetic disruption of Sin1 (i.e., Sin1 (32) . There was strong type I IFN-dependent Pras40 phosphorylation in Rictor +/+ MEFs, but not in Rictor −/− MEFs (Fig. 1D) , further demonstrating the requirement of Rictor for IFN-inducible AKT activity. Similarly, IFN-dependent Pras40 phosphorylation was induced in Sin1 +/+ and mLST8 +/− MEFs, but not in Sin1
−/− and mLST8 −/− MEFs (Fig. S2) . Together, these studies established that mTORC2 complexes are essential for IFN-induced AKT phosphorylation and activation.
As IFN-dependent activation of mTOR and its effectors occurs downstream of AKT (14), we examined the effects of targeted disruption of Rictor on IFN-inducible phosphorylation of downstream effectors of mTOR. IFN-α induced phosphorylation of p70 S6K on Thr-389 ( Fig. 2A) and phosphorylation of its downstream effector rpS6 (Fig. 2B ) in WT MEFs, but this phosphorylation was substantially decreased in Rictor −/− MEFs ( Fig. 2 A  and B, respectively) . IFN-α-induced p70S6K phosphorylation was also defective in Sin1 −/− MEFs (Fig. 2C) . Although there were higher basal levels of rpS6 phosphorylation in Sin1
MEFs, possibly reflecting compensation by another kinase, IFNdependent induction of rpS6 phosphorylation was not observed (Fig. 2D) . Moreover, in studies using mLST8 −/− MEFs, we noticed defective type I IFN-dependent phosphorylation of S6K and rpS6 ( Fig. 2 E and F (Fig. 2L ). Previous reports have demonstrated that insulin-or growth factor-induced phosphorylation of S6K is similar in Rictor-KO cells and parental cells that express Rictor (27, 30) . Because our data suggested defective IFN-dependent engagement of S6K and rpS6, we compared the induction of phosphorylation of S6K in response to type I IFN treatment, insulin, or serum treatment in Rictor +/+ and Rictor −/− MEFs. As shown in Fig. 3A , there was induction of Thr389 S6K phosphorylation by IFN-α, insulin, or serum in Rictor +/+ MEFs. Insulin and serum induced phosphorylation of S6K in immortalized MEFs with disruption of the Rictor gene (30) , but this phosphorylation was not seen in response to IFN treatment of Rictor −/− MEFs ( Fig. 3A and Fig. S3 ). Similarly, by using MEFs from a different Rictor KO (27), we found that there was very weak S6K phosphorylation in response to type I IFN-treatment, whereas insulin or serum induced S6K phosphorylation (Fig. S4 ). In addition, insulin or serum induced rpS6 phosphorylation at Ser-235/236 in Rictor +/+ and Rictor −/− MEFs, but IFN treatment did not result in rpS6 phosphorylation in Rictor −/− MEFs (Fig. 3B ). IFN-induced phosphorylation of Pras40 on Thr246 was also diminished compared with insulin and serum in Rictor −/− MEFs ( Fig. 3C and Fig. S4 ). We next examined whether the function of Rictor is required for expression of ISGs. We determined the IFN-inducible expression of ISG15, a protein whose function is critical for the antiviral effects of type I IFNs (33) . There was a strong induction of ISG15 expression in Rictor +/+ MEF cells treated with IFN-α or IFN-β, but this induction was defective in Rictor −/− MEFs (Fig. 4A ). We also assessed whether Rictor expression is required for induction of ISG54, a protein product implicated in IFN-inducible antiviral and proapoptotic properties (34, 35) . There was strong induction of ISG54 by IFN-α and IFN-β in Rictor +/+ MEFs, but this induction was defective in Rictor
MEFs (Fig. 4B) . In parallel studies, we found strong induction of ISG15 and ISG54 expression in Sin1 +/+ MEFs, but there was much weaker induction in Sin1 −/− MEFs ( Fig. 4 C and D). Similar results were obtained when mLST8 −/− MEFs were used, in which case a decrease in induction of ISG15 and ISG54 expression by IFNs was observed compared with mLST8 +/− cells (Fig. 4 E and F) . Thus, various components of the mTORC2 complex appear to play critical roles in regulating expression of ISG proteins with key functions as mediators of IFN responses. To further establish the role of mTORC2 complexes in IFNmediated ISG15 and ISG54 protein expression, in a system other than MEF cells, we generated U937 cells with stable knockdown of Rictor by using lentiviral vectors (Fig. 4G) . In experiments in which control shRNA or Rictor shRNA-infected U937 cells were treated with human IFN-α, and induction of ISG15 and ISG54 was studied, we found decreased expression of ISG15 and ISG54 in cells with stable knockdown of Rictor (Fig. 4 H and I) , consistent with the results of studies that used Rictor −/− MEFs. In subsequent studies, we sought to determine the mechanisms that may account for impaired ISG protein expression in Rictor KO cells. We performed reporter assays using a luciferase construct that included the WT ISG15 interferon-stimulated response element (ISRE) promoter element. We provide evidence for induction of luciferase activity in parental Rictor +/+ and mLST8
MEFs in response to type I IFN treatment, but this induction was clearly decreased in Rictor −/− and mLST8 −/− MEFs ( Fig. 5 A-C) . Taken together, these reporter assays suggested that mTORC2 complexes regulate downstream cellular pathways that are ultimately required for optimal transcription of ISGs. As our studies indicated impaired IFN-inducible engagement of mTOR effectors required for mRNA translation of ISGs in Rictor −/− cells, we sought to determine whether defects consistent with impaired ISG mRNA translation are noticeable in Rictor −/− MEFs. Rictor
and Rictor −/− MEFs were treated with IFN-α, polysomal mRNA was fractionated (Fig. 5D) , and quantitative real-time RT-PCR was used to determine the amount of ISG15 mRNA in polysome fractions. ISG15 mRNA levels were decreased in Rictor −/− MEFs compared with Rictor +/+ MEFs (Fig. 5E) , indicating a reduction of ISG15 mRNA in polysomes in the absence of Rictor. There was also a reduction in induction of total ISG15 mRNA (Fig. 5F) , consistent with the observed decreased inducible gene transcription via ISRE elements in reporter assays (Fig. 5 A and B) . Thus, although the decrease in polysomal ISG15 mRNA is consistent with the impaired engagement of mTOR effectors whose function is required for initiation of mRNA translation (Fig. 2) , it may reflect the decrease in total mRNA translation that apparently results from impaired transcription.
As MEFs responded to the protective effects of IFN-α treatment in a dose-dependent manner, identical IFN-α doses provided very weak protection in the Rictor −/− MEFs, despite being infected with lower doses of EMCV (Fig. 5G ). Similar studies, to address the role of mLST8 in IFN-inducible antiviral response, revealed that mLST8
MEFs exhibited a weaker IFN-induced antiviral response as compared with their mLST8 +/− counterparts (Fig. 5H ). Taken together, these studies established that the mTORC2 complex plays a critical role in the generation of IFN-induced antiviral responses, a finding consistent with the observed defective expression of ISG proteins in cells with disrupted mTORC2 formation.
Discussion
It is well established that the AKT/mTOR pathway is engaged subsequent to the activation of IFN receptors, and accumulating evidence points to important roles for this cascade in the generation of the biological effects of IFNs (6, 17) . Previous studies have shown that IFNs induce the formation of translation initiation complexes by activating mTOR (13) . In studies that used cells with targeted disruption of the 4E-BP1 and TSC genes, it was shown that TSC1/2 and the translational repressor 4E-BP1 are negative upstream and downstream effectors, respectively, of IFN-activated mTOR, whereas expression of ISG15, CXCL10, and IFN-induced antiviral responses were enhanced in cells lacking 4E-BP1 or TSC2 (13) . Other work has demonstrated that generation of IFN-dependent mTOR (mTORC1) signals and IFN-inducible cap-dependent mRNA translation are regulated upstream by AKT kinases, which are engaged by the type I and II IFN receptors (14) . Remarkably, IFN-dependent antiviral responses are defective in the absence of AKT 1/2 (14), providing evidence that, beyond antiapoptotic responses, the AKT pathway promotes an IFN-antiviral state.
The initial demonstration that the mTOR pathway is activated by IFNs (11) was surprising and somewhat unexpected, as mTOR is a regulator of cap-dependent mRNA translation for oncogenic genes and mediates cell proliferation signals. Understanding the differences and mechanisms of specificity accounting for mTOR- mediated responses to IFNs, which are cytokines with growthinhibitory properties, vs. growth factors and oncogenic signals, has been challenging. To date, no differences have been identified on the patterns of phosphorylation/mechanisms of engagement of downstream mTOR effectors. However, the identification of specific ISGs as target products of the mTOR cascade (13) (14) (15) (16) (17) has suggested that coordination of activation of JAK-STAT pathways that control IFN-dependent gene transcription and simultaneous engagement of AKT/mTOR pathways provide an integrated signaling network for generation of IFN-inducible proteins that mediate antiviral and antiproliferative responses. mTOR exists in two distinct complexes, mTORC1 and mTORC2 (24, 29, 36) . Both complexes share mTOR as their catalytic subunit and comprise common and distinct elements. mTORC1 includes mTOR, Raptor, and mLST8 in its structure, whereas mTORC2 includes mTOR, Rictor, mLST8, and Sin1 (24, 36) . mTORC1 complexes are targeted by classic mTOR inhibitors such as rapamycin or RAD001, whereas new catalytic inhibitors of mTOR target and inhibit mTORC1 and mTORC2 complexes (37) . Because mTORC2 regulates phosphorylation and activation of AKT, which mediates antiapoptotic responses, these complexes are considered good targets for new anticancer agents aimed to block antiapoptotic responses in malignant cells. Indeed, dual mTORC1/mTORC2 inhibitors exhibit more potent antileukemic effects in vitro and in vivo compared with specific mTORC1 targeting agents, underscoring the importance of mTORC2 complexes in proliferation and survival of malignant cells (38) (39) (40) . Although the sequence of events for activation of mTORC1 complexes has been well established (25) , relatively little is known about the mechanisms of mTORC2 activation. Recent evidence has suggested that mTORC2 can be activated in a PI3 kinase-dependent manner under certain circumstances (41) . Notably, in previous work, we demonstrated that the PI3 kinase pathway is also engaged by type I IFN receptors (42) and ultimately regulates cap-dependent mRNA translation by controlling the mTOR pathway (16) . There are also recent reports providing evidence that association with ribosomes is essential for activation of mTORC2 complexes (43, 44) .
As the function of mTORC2 in the IFN system has been unknown, we sought to identify the roles of mTORC2 complexes in type I IFN signaling and biological responses. By using MEFs with genetic disruption of three different components of the mTORC2 , and mLST8 −/− cells, establishing that mTORC2 is required for AKT engagement in response to type I IFNs. Importantly, we noticed decreased or defective phosphorylation of downstream mTORC1 effectors, such as S6K, rpS6, and 4E-BP1, likely reflecting the requirement for AKT activity (14) in the generation of these type I IFN-signaling events. In other studies, we found that inducible expression of ISG15 and ISG54 proteins is defective in the absence of intact mTORC2 complexes. Further studies established the presence of a transcriptional defect for ISRE elements in Rictor −/− cells, suggesting a mechanism for the defective ISG expression. Although the observed decreased ISG mRNA expression in polysomal fractions is difficult to interpret in the context of simultaneously defective gene transcription, it is possible that ISG mRNA translation is also affected in cells with disrupted mTORC2 complexes, as suggested by the decreased IFN-induced phosphorylation of S6K and 4E-BP1 in these cells. In the absence of specifics relating to the precise mechanism, our data established that defective ISG protein expression in Rictor-KO cells results in defective antiviral responses.
Beyond establishing an important role for mTORC2 complexes in the generation of IFN responses, the results of this study suggest a unique function of mTORC2 in the IFN system, distinct from its function in growth factor signaling and proliferative responses. Previous reports have shown that genetic KO of Rictor does not affect growth factor-dependent activation of S6K and rpS6 (27, 30) . Beyond Rictor, Sin1 is required for AKT stability and folding, and, as a part of mTORC2 complexes (45) , the function of Sin1 is required for phosphorylation of AKT on Ser-473 (31). On the contrary, insulin-and serum-induced phosphorylation of S6K and 4E-BP1 phosphorylation on Thr-37/ 46 was not blocked in Sin1-KO cells (31) . In studies using MEFs from two different Rictor KOs (27, 30) , we found that IFN-inducible phosphorylation of S6K on Thr-389 and rpS6 on Ser-235/ 236 was completely defective or very weak in Rictor −/− MEFs compared with phosphorylation in response to insulin or serum as analyzed in parallel. The reasons for these differences are not clear, but these data establish a relative selectivity and specificity in the IFN system that may account for differential responses invoked by IFNs vs. growth factors. Although the precise mechanisms of differential mTORC2-controlled signaling in response to IFNs vs. oncogenic signals remain to be defined, these results raise the potential of future therapeutic exploitation of these differences to selectively target malignant cells. EMCV at an MOI of 0.01 and were incubated for 17 h. Culture medium containing the virus was then collected, and viral titers were determined by standard plaque assay in HeLa cells. The experiment shown is representative of five independent experiments, and data represent means ± SE.
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